Growth Metrics

Gyre Therapeutics (GYRE) Share-based Compensation Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -34.72%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 4.80%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 10.78%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 2.55%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 20.65%
10 Gyre Therapeutics 532.38 Mn 518.25 Mn 8.38 Mn 130.84%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 130.84%
Dec 31, 2025 -27.93%
Sep 30, 2025 72.36%
Jun 30, 2025 37.83%
Mar 31, 2025 -0.52%
Dec 31, 2024 -6.02%
Sep 30, 2024 -30.73%
Jun 30, 2024 -74.66%
Mar 31, 2024 -77.95%
Dec 31, 2023 95.59%
Sep 30, 2023 -54.90%
Jun 30, 2023 -52.57%
Mar 31, 2023 -36.10%
Dec 31, 2022 163.53%
Sep 30, 2022 -34.61%
Jun 30, 2022 -27.37%
Mar 31, 2022 -14.67%
Dec 31, 2021 -2.64%
Sep 30, 2021 0.52%
Jun 30, 2021 21.28%
Mar 31, 2021 19.19%
Dec 31, 2020 44.17%
Sep 30, 2020 48.67%
Jun 30, 2020 95.86%
Mar 31, 2020 88.60%
Dec 31, 2019 72.82%
Sep 30, 2019 62.12%
Jun 30, 2019 76.23%
Mar 31, 2019 75.64%
Dec 31, 2018 57.06%
Sep 30, 2018 138.11%
Jun 30, 2018 137.75%
Mar 31, 2018 139.70%
Dec 31, 2017 77.39%
Sep 30, 2017 79.71%
Jun 30, 2017 -37.92%
Mar 31, 2017 -47.41%
Dec 31, 2016 26.70%
Sep 30, 2016 -34.92%
Jun 30, 2016 -36.84%
Mar 31, 2016 -54.40%
Dec 31, 2015 -48.25%
Sep 30, 2015 -61.18%
Jun 30, 2015 -72.93%
Mar 31, 2015 -71.58%
Dec 31, 2014 -69.83%
Sep 30, 2014 -60.45%
Jun 30, 2014 -21.05%
Mar 31, 2014 -27.48%
Dec 31, 2013 -72.44%
Sep 30, 2013 3.01%
Jun 30, 2013 9.93%